• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Subcutaneous Tocilizumab May Be Less Effective than Intravenous Tocilizumab in the Treatment of Juvenile Idiopathic Arthritis-associated Uveitis.

作者信息

Quesada-Masachs Estefania, Caballero Consuelo Modesto

机构信息

Department of Rheumatology, Pediatric Rheumatology Unit, Hospital Universitario Vall d'Hebron.

Department of Rheumatology, Pediatric Rheumatology Unit, Hospital Universitario Vall d'Hebron, Barcelona, Spain.

出版信息

J Rheumatol. 2017 Feb;44(2):260-261. doi: 10.3899/jrheum.160908.

DOI:10.3899/jrheum.160908
PMID:28148759
Abstract
摘要

相似文献

1
Subcutaneous Tocilizumab May Be Less Effective than Intravenous Tocilizumab in the Treatment of Juvenile Idiopathic Arthritis-associated Uveitis.皮下注射托珠单抗在治疗幼年特发性关节炎相关葡萄膜炎方面可能不如静脉注射托珠单抗有效。
J Rheumatol. 2017 Feb;44(2):260-261. doi: 10.3899/jrheum.160908.
2
Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis?托珠单抗是治疗与幼年特发性关节炎相关的难治性葡萄膜炎的有效选择吗？
J Rheumatol. 2012 Jun;39(6):1294-5. doi: 10.3899/jrheum.120010.
3
Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: A report of two cases.托珠单抗治疗幼年特发性关节炎相关难治性葡萄膜炎：两例报告。
J Clin Pharm Ther. 2019 Jun;44(3):482-485. doi: 10.1111/jcpt.12821. Epub 2019 Feb 27.
4
Subcutaneous Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis.皮下注射托珠单抗治疗幼年特发性关节炎相关葡萄膜炎。
Ocul Immunol Inflamm. 2023 Dec;31(10):1997-2000. doi: 10.1080/09273948.2022.2161916. Epub 2023 Jan 19.
5
Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.托珠单抗作为治疗幼年特发性关节炎相关难治性葡萄膜炎的一种选择的证据。
J Rheumatol. 2016 Dec;43(12):2183-2188. doi: 10.3899/jrheum.160231. Epub 2016 Sep 15.
6
Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan.托珠单抗用于全身型幼年特发性关节炎的长期治疗：日本一项开放标签扩展研究的结果
Ann Rheum Dis. 2013 Apr;72(4):627-8. doi: 10.1136/annrheumdis-2012-202310. Epub 2012 Nov 30.
7
Tocilizumab Employment in the Treatment of Resistant Juvenile Idiopathic Arthritis Associated Uveitis.托珠单抗治疗耐药性幼年特发性关节炎相关葡萄膜炎的应用。
Ocul Immunol Inflamm. 2021 Jan 2;29(1):14-20. doi: 10.1080/09273948.2020.1817501. Epub 2020 Oct 6.
8
Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study.从静脉注射托珠单抗转换为皮下注射托珠单抗治疗幼年特发性关节炎患者的患者满意度和临床疗效：一项观察性研究。
Rheumatol Int. 2020 Jul;40(7):1111-1116. doi: 10.1007/s00296-020-04596-3. Epub 2020 May 16.
9
Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial.静脉注射托珠单抗治疗 2 岁以下全身型幼年特发性关节炎患儿：一项开放标签的 1 期临床试验结果。
Pediatr Rheumatol Online J. 2019 Aug 22;17(1):57. doi: 10.1186/s12969-019-0364-z.
10
Tocilizumab for treating juvenile idiopathic arthritis.托珠单抗治疗幼年特发性关节炎。
Expert Opin Biol Ther. 2016;16(4):559-66. doi: 10.1517/14712598.2016.1150997. Epub 2016 Feb 27.

引用本文的文献

1
Long-term effects of tocilizumab on retinal and choroidal inflammation in Birdshot uveitis.托珠单抗对鸟枪弹样脉络膜视网膜炎视网膜和脉络膜炎症的长期影响。
J Ophthalmic Inflamm Infect. 2024 Nov 21;14(1):61. doi: 10.1186/s12348-024-00443-9.
2
Use of immunomodulators in non-infectious uveitis: lights and shadows.免疫调节剂在非感染性葡萄膜炎中的应用：利弊并存。
Eye (Lond). 2024 Dec;38(17):3231-3242. doi: 10.1038/s41433-024-03294-9. Epub 2024 Aug 19.
3
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report.
皮下注射托珠单抗治疗儿童非感染性葡萄膜炎：简短报告。
Pediatr Rheumatol Online J. 2023 Sep 12;21(1):99. doi: 10.1186/s12969-023-00883-y.
4
Efficacious switching from subcutaneous to intravenous tocilizumab in patients with non-infectious non-anterior uveitis.非感染性非前葡萄膜炎患者从皮下注射托珠单抗有效转换为静脉注射托珠单抗。
J Ophthalmic Inflamm Infect. 2023 Jul 18;13(1):32. doi: 10.1186/s12348-023-00336-3.
5
Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review.托珠单抗治疗青少年特发性关节炎相关性葡萄膜炎：一篇叙述性综述
Children (Basel). 2023 Feb 23;10(3):434. doi: 10.3390/children10030434.
6
Tocilizumab promotes repair of spinal cord injury by facilitating the restoration of tight junctions between vascular endothelial cells.托珠单抗通过促进血管内皮细胞紧密连接的恢复促进脊髓损伤的修复。
Fluids Barriers CNS. 2023 Jan 9;20(1):1. doi: 10.1186/s12987-022-00399-9.
7
[Association of the different forms of uveitis with inflammatory rheumatic diseases and their treatment].[不同类型葡萄膜炎与炎性风湿性疾病的关联及其治疗]
Z Rheumatol. 2022 Oct;81(8):667-681. doi: 10.1007/s00393-022-01244-y. Epub 2022 Aug 30.
8
Tocilizumab and Abatacept for the Treatment of Childhood Chronic Uveitis: A Monocentric Comparison Experience.托珠单抗和阿巴西普治疗儿童慢性葡萄膜炎：单中心比较经验
Front Pediatr. 2022 Apr 12;10:851453. doi: 10.3389/fped.2022.851453. eCollection 2022.
9
Biologics in juvenile idiopathic arthritis-main advantages and major challenges: A narrative review.青少年特发性关节炎中的生物制剂——主要优势与重大挑战：一篇叙述性综述。
Arch Rheumatol. 2020 Jun 25;36(1):146-157. doi: 10.46497/ArchRheumatol.2021.7953. eCollection 2021 Mar.
10
Recent advances in the treatment of juvenile idiopathic arthritis-associated uveitis.青少年特发性关节炎相关葡萄膜炎治疗的最新进展
Ther Adv Ophthalmol. 2021 Feb 18;13:2515841420984572. doi: 10.1177/2515841420984572. eCollection 2021 Jan-Dec.